Quantcast

Latest Organofluorides Stories

2015-03-20 20:21:28

PHILADELPHIA, March 20, 2015 /PRNewswire/ -- A Philadelphia jury today affirmed by a 10-2 vote that Janssen Pharmaceuticals, a division of Johnson & Johnson, failed to warn of the risk to

2015-03-18 16:26:52

WASHINGTON, March 18, 2015 /PRNewswire/ -- USPLabs Inc. has been made aware that U.S.

2015-03-17 16:27:03

--- Significant Survival Benefit Observed in Pre-Specified Subgroups Including Patients with Brain Metastases and Patients with Baseline Liver Metastases --- SAN FRANCISCO, March

2015-03-17 08:37:26

DALLAS, March 17, 2015 /PRNewswire/ -- The report "Fluorosurfactants Market by Type (Amphoteric, Nonioninc, Anionic and Cationic), by Application (Paints & Coatings,

2015-03-12 23:02:01

The Firm is looking forward to a status conference on March 19, 2015 that will discuss issues that affect hundreds of Risperdal lawsuit claimants. New York,

2015-03-09 16:34:05

DUBLIN, March 9, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has launched a generic version of Fougera's Temovate(®)

2015-03-08 23:00:51

The Firm is representing numerous plaintiffs who have filed Risperdal lawsuits in Pennsylvania that allege the antipsychotic medication caused gynecomastia, or male breast development.

2015-03-05 23:01:15

The Firm is representing numerous clients in Risperdal lawsuits that have been filed in the Pennsylvania mass tort proceeding, all of whom allegedly developed gynecomastia due to treatment with

2015-03-05 08:33:08

NORWALK, Conn., March 5, 2015 /PRNewswire/ -- UBM Medica US announces that OncoTherapy Network,

2015-03-05 08:32:19

BAUDETTE, Minn., March 5, 2015 /PRNewswire/ -- ANI Pharmaceuticals, Inc.